AFYA or LOPE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE). But which of these two stocks presents investors with the better value opportunity right now?
Should Value Investors Buy Afya (AFYA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Value Stocks to Buy for March 23rd
LCUT, AFYA and JLL made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 23, 2026.
Surging Earnings Estimates Signal Upside for Afya (AFYA) Stock
Afya (AFYA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 27.62% Upside in Afya (AFYA): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bamco Inc. NY Cuts Stock Holdings in Afya Limited $AFYA
Bamco Inc. NY lowered its position in shares of Afya Limited (NASDAQ: AFYA) by 11.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,729,805 shares of the company's stock after selling 221,559 shares during the period. Bamco Inc. NY
Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
Afya (AFYA) Tops Q4 Earnings Estimates
Afya (AFYA) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.36 per share a year ago.
Are Investors Undervaluing Afya (AFYA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Afya Limited (AFYA) Q3 2025 Earnings Call Transcript
Afya Limited ( AFYA ) Q3 2025 Earnings Call November 12, 2025 5:00 PM EST Company Participants Renata Couto - Investor Relations Executive Manager Virgilio Deloy Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Lucca Marquezini - Itaú Corretora de Valores S.A., Research Division Lucas Nagano - Morgan Stanley, Research Division Marcelo Santos - JPMorgan Chase & Co, Research Division Mirela Rodrigues de Oliveira - BofA Securities, Research Division Renan Prata - Citigroup Inc. Exchange Research Presentation Renata Couto Investor Relations Executive Manager Thank you for joining us for Afya's conference call.
Afya (AFYA) Q3 Earnings Beat Estimates
Afya (AFYA) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.32 per share a year ago.
Afya's Multiple Is Back To Reasonable Levels, But Market Saturation Is Real
Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer expansion opportunities and a focus on shareholder returns.
